Table 1 Clinical and pathological characteristics of subjects in this study.

From: Serum small extracellular vesicles-derived BST2 as a biomarker for papillary thyroid microcarcinoma promotes lymph node metastasis

Characteristics

PTMC

BN

with NLNM

with LNM

Sample size

10

10

9

Age at operation [y, X ± S]

40.60 ± 10.93

39.10 ± 9.78

41.10 ± 9.89

Sex [n (%)]

 Female

5 (50.0)

5 (50.0)

5 (55.6)

 Male

5 (50.0)

5 (50.0)

4 (44.4)

Family history of thyroid disease [n (%)]

 No

9 (90.0)

9 (90.0)

\

 Yes

1 (10.0)

1 (10.0)

\

Tumor size [cm, X ± S]

 ≤ 0.5

2 (20.0)

2 (20.0)

\

 > 0.5

8 (80.0)

8 (80.0)

\

Clinical LNM [n (%)]

 Absent

10 (100.0)

4 (40.0)

\

 Present

0 (0.0)

6 (60.0)

\

Pathological subtype [n (%)]

 Classic

7 (70.0)

6 (60.0)

\

 Follicular variant

1 (10.0)

1 (10.0)

\

 Classic and follicular variant

2 (20.0)

3 (30.0)

\

Tumor location [n (%)]

 Unifocal

8 (80.0)

6 (60.0)

\

 Multifocal

2 (20.0)

4 (40.0)

\

Tumor calcification [n (%)]

 Absent

9 (90.0)

8 (80.0)

\

 Present

1 (10.0)

2 (20.0)

\

Microscopic capsular invasion [n (%)]

 Absent

4 (40.0)

4 (40.0)

\

 Present

6 (60.0)

6 (60.0)

\

Hashimoto’s thyroiditis [n (%)]

 Absent

8 (80.0)

8 (80.0)

\

 Present

2 (20.0)

2 (20.0)

\

  1. PTMC papillary thyroid microcarcinoma, BN healthy controls, LNM lymph node metastasis; NLNM with non-LNM. Data are presented as mean ± standard deviation or n (%).